ANN JABLON — Lobbyist Profile | Poliscope

ANN JABLON

Reported covered position: Chief of Staff, Congressman Richard Neal

Filings

Clients

Firms

Years active

2017–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
MASSACHUSETTS BIOTECHNOLOGY COUNCIL	39	2017–2026

Lobbying firms

Firm	Filings	Years
MASSACHUSETTS BIOTECHNOLOGY COUNCIL	39	2017–2026

Original LDA source filings (39)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2026 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2026 · first_quarter · Q1

Firm income: —

Source: Senate LDA

Show 35 more original filings

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2025 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2025 · first_quarter · Q1

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2024 · fourth_quarter · Q4

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2024 · third_quarter · Q3

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2024 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2024 · first_quarter · Q1

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2023 · fourth_quarter · Q4

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2023 · third_quarter · 3A

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2023 · third_quarter · Q3

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2023 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2023 · first_quarter · Q1

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation as it relates to the biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2022 · fourth_quarter · Q4

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry. Advocacy for bringing newly formed ARPA-Hs (Advanced Research Projects Agency for Health) headquarters to Massachusetts.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2022 · third_quarter · Q3

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry. Advocacy for bringing newly formed ARPA-Hs (Advanced Research Projects Agency for Health) headquarters to Massachusetts.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2022 · second_quarter · Q2

Firm income: —Client expense: $40,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry. Advocacy for bringing newly formed ARPA-Hs (Advanced Research Projects Agency for Health) headquarters to Massachusetts.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2022 · first_quarter · Q1

Firm income: —Client expense: $15,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2021 · fourth_quarter · Q4

Firm income: —Client expense: $15,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2021 · third_quarter · Q3

Firm income: —Client expense: $15,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2021 · second_quarter · Q2

Firm income: —Client expense: $15,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2021 · first_quarter · Q1

Firm income: —Client expense: $15,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MMM

Medicare/Medicaid

Monitor health and tax legislation relating to biotechnology industry

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2020 · fourth_quarter · Q4

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2020 · third_quarter · Q3

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2020 · second_quarter · Q2

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2020 · first_quarter · Q1

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2019 · fourth_quarter · Q4

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2019 · third_quarter · Q3

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2019 · second_quarter · Q2

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2019 · first_quarter · Q1

Firm income: —Client expense: $25,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2018 · fourth_quarter · Q4

Firm income: —Client expense: $20,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2018 · third_quarter · Q3

Firm income: —Client expense: $20,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2018 · second_quarter · Q2

Firm income: —Client expense: $20,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2018 · first_quarter · Q1

Firm income: —Client expense: $20,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2017 · fourth_quarter · Q4

Firm income: —Client expense: $20,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2017 · third_quarter · Q3

Firm income: —Client expense: $20,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2017 · second_quarter · Q2

Firm income: —Client expense: $50,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE

MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL

2017 · first_quarter · Q1

Firm income: —Client expense: $50,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

Monitor health anfd tax legislation pertaining to biotechnology industry.

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE